Table 1.
Clinicopathological features | No. of patients | P value | ||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
DFS | miR-34a | miR-34b | miR-34c | miR-31 | miR-192 | miR-215 | ||
Age (years) | 0.378 | 0.503 | 0.452 | 0.621 | 0.257 | 0.343 | 0.250 | |
≤55 | 43 (53.8%) | |||||||
>55 | 37 (46.2%) | |||||||
Gender | 0.364 | 0.593 | 0.143 | 0.221 | 0.689 | 0.506 | 0.477 | |
Male | 46 (57.5%) | |||||||
Female | 34 (42.5%) | |||||||
Anatomic location | 0.435 | 0.407 | 0.217 | 0.230 | 0.241 | 0.121 | 0.730 | |
Tibia/femur | 59 (73.8%) | |||||||
Elsewhere | 21 (26.2%) | |||||||
Tumor size (cm) | 0045* | 0. 025* | 0.348 | 0.022* | 0.101 | 0.237 | 0.049* | |
≤8 | 50 (62.5%) | |||||||
>8 | 30 (37.5%) | |||||||
Clinical stage | 0.003* | 0.045* | 0.204 | 0.272 | 0.067 | 0.371 | 0.769 | |
IIA | 19 (23.8%) | |||||||
IIB/III | 61 (76.2%) | |||||||
Distant metastasis | 0.004* | 0. 990 | 0.125 | 0.103 | 0.034* | 0.283 | 0.106 | |
Negative | 31 (38.8%) | |||||||
Positive | 49 (61.2%) | |||||||
Response to chemotherapy | 0.037* | 0.098 | 0.190 | 0.337 | 0.308 | 0.018* | 0.031* | |
Good | 33 (41.3%) | |||||||
Poor | 47 (58.7%) | |||||||
P53 expression | 0.001* | 0.078 | 0.194 | 0.451 | 0.154 | 0.012* | 0.046* | |
High | 20 (25.0%) | |||||||
Low | 60 (75.0%) |